Robuta

https://iro.uiowa.edu/esploro/outputs/abstract/Cardiovascular-toxicity-with-androgen-receptor-pathway-inhibitors/9985142056702771?institution=01IOWA_INST&skipUsageReporting=true&recordUsage=false Cardiovascular toxicity with androgen-receptor pathway inhibitors in metastatic prostate cancer: A... 145 Background: Multiple trials have demonstrated addition of androgen-receptor pathway inhibitors (ARPIs) improve survival in patients with metastatic... metastatic prostate cancerandrogen receptorpathway inhibitors https://pubmed.ncbi.nlm.nih.gov/30340782/ Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to... Platinum-based regimens have not been proved to increase survival from advanced prostate cancer (PCa). Incontrovertible evidence that a proportion of prostate... metastatic prostate cancergenomic analysis https://boris-portal.unibe.ch/entities/publication/69453632-9258-46b6-881b-333826e76b53 Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a... Background Metformin is a widely used anti-diabetic drug. Several studies have suggested that metformin has anticancer activity in some malignancies, including... metastatic prostate cancerfor patients https://ce.massmed.nejm.org/nejm-weekly-cme/content/metastatic-prostate-cancer Metastatic Prostate Cancer | MMS/NEJM Continuing Education Center metastatic prostate cancercontinuing educationmmsnejmcenter https://www.mdpi.com/2072-6694/15/15/3998 Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression The positivity rate of circulating tumor DNA (ctDNA) next-generation sequencing (NGS) varies among patients with metastatic prostate cancer (mPC), complicating... metastatic prostate cancerdna analysiscirculatingtumor https://www.wikidata.org/wiki/Q33730189 Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer - Wikidata metastatic prostate cancer https://www.cms.gov/medicare-coverage-database/view/nca.aspx?ncaid=247 NCA - Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer (CAG-00422N) Use this page to view details for NCA - Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer (CAG-00422N). metastatic prostate cancerimmunotherapy treatmentncaautologouscellular https://data.mendeley.com/datasets/848tsfvzd5/2 Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing... NGS calls and RAD51 IF results for the Arce-Gallego et al, Cell Reports Medicine 2025. metastatic prostate cancerhomologous recombinationrepair status https://www.repository.cam.ac.uk/items/6d1ef7d7-0479-4165-910d-8cd7472ee360 Individualising prognostic stratification in non-metastatic prostate cancer: the development,... Decision-making around treatment for non-metastatic prostate cancer is complex, with radical treatment associated with significant potential morbidity despite... metastatic prostate cancerprognosticstratificationnondevelopment https://www.innovative-ctu.ucl.ac.uk/news/news-stories/2023/july/which-people-with-metastatic-prostate-cancer-benefit-most-from-upfront-docetaxel/ Which people with metastatic prostate cancer benefit most from upfront docetaxel? | UCL Innovative... metastatic prostate cancer https://www.cancerresearchuk.org/about-cancer/prostate-cancer/metastatic-cancer/treatment/treating-symptoms Treating symptoms of metastatic prostate cancer | Cancer Research UK Symptoms of metastatic or advanced prostate cancer include bone pain, problems passing urine and tiredness. Doctors and nurses can support you and give... metastatic prostate cancertreatingsymptomsresearchuk https://www.cancer.gov/news-events/cancer-currents-blog/2022/darolutamide-survival-metastatic-prostate-cancer Darolutamide Extends Survival in Metastatic Prostate Cancer - NCI Adding darolutamide (Nubeqa) to ADT and docetaxel improves survival in hormone-sensitive metastatic prostate cancer, results from the ARASENS trial show. metastatic prostate cancerdarolutamideextendssurvivalnci https://cancerchat.cancerresearchuk.org/f/ask-the-nurses/128710/husband-with-metastatic-prostate-cancer Husband with metastatic prostate cancer - Ask the nurses - Cancer Chat | Cancer Research UK Hi there, Mike ( 83 years) was diagnosed with stage 4 prostate cancer ( gleason 5+5=10) just under three years ago. He competed a six weekly chemotherapy course metastatic prostate cancerask the nurseshusband https://pubmed.ncbi.nlm.nih.gov/34336233/ Androgen deprivation monotherapy usage in non-metastatic prostate cancer: results from eight... Our multinational survey provides evidence that PC management varies across European countries and with clinical context, and frequently diverges from European... metastatic prostate cancer https://sciencedaily.com/releases/2022/04/220413131202.htm Novel therapeutic agents may reduce the oncogenesis of metastatic prostate cancer | ScienceDaily Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and homologous cyclin-dependent kinase 8 (CDK8)... metastatic prostate cancer https://researchconnect.buffalo.edu/en/publications/myosin-isoform-expressed-in-metastatic-prostate-cancer-stimulates/ Myosin isoform expressed in metastatic prostate cancer stimulates cell invasion - SUNY University... metastatic prostate cancer https://brane-space.blogspot.com/2025/05/androgen-deprivation-therapy-what.html Brane Space: Androgen Deprivation Therapy: What Metastatic Prostate Cancer Patients (Like Joe... Joe Biden now faces his own battle with metastatic prostate cancer ADT ( androgen deprivation therapy) is no walk ... metastatic prostate cancer https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2023.1081951/full Frontiers | Cervical lymphadenopathy as initial presentation of metastatic prostate cancer: A... Cervical lymphadenopathy as the initial presentation of metastatic prostate cancer is particularly uncommon, and easily misdiagnosed. In the current study, w... metastatic prostate cancercervical lymphadenopathyfrontiersinitial https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=768111 I01CX002622-01 - Predicting Metastatic Progression of High Risk Localized Prostate Cancer high riskpredictingmetastaticprogression https://pubmed.ncbi.nlm.nih.gov/31192170/ Impact of tumor cytoreduction in metastatic prostate cancer impacttumormetastaticprostatecancer https://pure.psu.edu/en/publications/metastatic-epidural-spinal-cord-compression-among-elderly-patient/ Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer -... spinal cord compression https://www.health.harvard.edu/blog/prostate-cancer-zapping-metastatic-tumors-with-radiation-improves-survival-202211072843 Prostate cancer: Zapping metastatic tumors with radiation improves survival - Harvard Health Nov 7, 2022 - When prostate cancer spreads beyond the gland, it has been treated with hormone therapy, but there are challenging side effects. A new study shows that a... prostate cancerzappingmetastatictumors https://researchdiscovery.drexel.edu/esploro/outputs/doctoral/The-role-of-interleukin-1-beta-in/991014695248104721 The role of interleukin-1 beta in metastatic colonization of prostate cancer cells - Drexel... Metastatic Prostate Cancer (mPCa) presents a 5-year survival rate of 29% and is currently incurable. Previous work from our group determined that skeletal... https://pubmed.ncbi.nlm.nih.gov/22995653/?dopt=Abstract Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall... This final analysis confirms that abiraterone acetate significantly prolongs overall survival in patients with metastatic castration-resistant prostate cancer... abiraterone acetate https://pubmed.ncbi.nlm.nih.gov/27591931/?dopt=Abstract EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and... In men with a rise in their PSA levels after prior local treatment for prostate cancer only, it is important to balance overtreatment against further... https://dukespace.lib.duke.edu/items/428bcc7e-93c5-419e-a371-b0c1fa2a9cc1 How I do it: Apalutamide use in non-metastatic castrate resistant prostate cancer. Urologists have been using oral nonsteroidal antiandrogens (AA) for 30 years as a component of combined androgen blockade. In February 2018, a new third... how i do it https://pubmed.ncbi.nlm.nih.gov/21612468/ Abiraterone and increased survival in metastatic prostate cancer The inhibition of androgen biosynthesis by abiraterone acetate prolonged overall survival among patients with metastatic castration-resistant prostate cancer... abirateroneincreasedsurvivalmetastaticprostate https://pure.psu.edu/en/publications/investigating-the-usage-of-abiraterone-in-african-american-men-wi/ Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer -... https://edrn.cancer.gov/data-and-resources/publications/25456366-267-rna-biomarkers-associated-with-metastatic-progression-in-prostate-cancer-a-multi-institutional-high-throughput-analysis-of-schlap1/ RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional... This is a publication by a member of the Early Detection Research Network. associated with https://pharma.economictimes.indiatimes.com/tag/metastatic+castration-resistant+prostate+cancer Metastatic castration resistant prostate cancer - Latest metastatic castration resistant prostate... ETPharma.com brings latest metastatic castration resistant prostate cancer news, views and updates from all top sources for the Indian Pharma industry. prostate cancermetastaticcastrationresistantlatest